1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hydroxyzine in 14 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (hydroxyzine) | Trials (hydroxyzine) | Recent Studies (post-2010) (hydroxyzine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,489 | 349 | 185 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordeiro, RS; e Silva, PM; Martins, MA; Pasquale, CP; Pires, AL; Rihoux, JP; Ruffié, C; Vargaftig, BB | 1 |
| Rihoux, JP | 1 |
| Coyle, AJ; Lefort, J; Vargaftig, BB | 1 |
| Hartnell, A; Kay, AB; Moqbel, R; Walsh, GM | 1 |
| Eliakim, R; Karmeli, F; Okon, E; Rachmilewitz, D | 1 |
| Fadel, R; Juhlin, L; Rihoux, JP | 1 |
| Juhlin, L; Rihoux, JP | 1 |
| Borgnon, A; David, B; Fadel, R; Herpin-Richard, N; Rassemont, R; Rihoux, JP | 1 |
| Juhlin, L | 1 |
| Bazill, GW; Dexter, TM | 1 |
| Capron, A; Capron, M; De Vos, C; Joseph, M; Leprevost, C; Tomassini, M; Vorng, H | 1 |
| Benveniste, J; Burtin, C; De Vos, C; Dubertret, L; Michel, L; Rihoux, JP | 1 |
| Capron, A; Capron, M; De Vos, C; Leprevost, C; Tomassini, M | 1 |
| Barbanoj, MJ; García-Gea, C; Izquierdo, I; Jané, F; Morte, A; Pérez, I | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxyzine
| Article | Year |
|---|---|
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade.
Topics: Cetirizine; Chemotaxis, Leukocyte; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzine; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Receptors, Histamine H1; Skin | 1991 |
3 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxyzine
| Article | Year |
|---|---|
In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.
Topics: Adult; Cetirizine; Chemotaxis, Leukocyte; Eosinophils; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Platelet Activating Factor; Skin; Skin Tests | 1990 |
Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.
Topics: Administration, Oral; Adolescent; Adult; Cetirizine; Eosinophils; Female; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Immediate; Male; Platelet Activating Factor; Skin | 1988 |
Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Topics: Adult; Analysis of Variance; Attention; Cross-Over Studies; Cyproheptadine; Decision Making; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Flicker Fusion; Follow-Up Studies; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Motor Activity; Neuropsychological Tests; Pain Measurement; Platelet Activating Factor; Psychomotor Performance; Reaction Time; Self-Assessment; Skin Tests; Statistics, Nonparametric; Time Factors | 2004 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxyzine
| Article | Year |
|---|---|
Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80.
Topics: Administration, Topical; Animals; Cetirizine; Chemotactic Factors, Eosinophil; Eosinophilia; Histamine H1 Antagonists; Hydroxyzine; In Vitro Techniques; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pleurisy; Rats; Rats, Inbred Strains; Time Factors | 1992 |
The effect of cetirizine on antigen-dependent leucopenia in the guinea-pig.
Topics: Animals; Benzeneacetamides; Benzhydryl Compounds; Blood Platelets; Cetirizine; Female; Guinea Pigs; Histamine H1 Antagonists; Hydroxamic Acids; Hydroxyzine; In Vitro Techniques; Leukocyte Count; Leukopenia; Leukotriene B4; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Pyrilamine; Terfenadine | 1991 |
Effects of cetirizine on human eosinophil and neutrophil activation in vitro.
Topics: Animals; Cell Adhesion; Cetirizine; Complement System Proteins; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzine; Immunoglobulin G; In Vitro Techniques; Monocytes; Neutrophils; Platelet Activating Factor; Rosette Formation; Schistosoma mansoni | 1991 |
Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
Topics: Animals; Azepines; Cimetidine; Ethanol; Gastric Acid; Gastric Mucosa; Gastrins; Hydroxyzine; In Vitro Techniques; Ketotifen; Leukotriene B4; Male; Mast Cells; Pepsin A; Peptide Fragments; Platelet Activating Factor; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; SRS-A; Substance P; Triazoles | 1991 |
Platelet-activating factor-induced immediate and late cutaneous reactions.
Topics: Cetirizine; Humans; Hydroxyzine; Platelet Activating Factor; Skin | 1991 |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria.
Topics: Adult; Blood Transfusion, Autologous; Cetirizine; Chronic Disease; Female; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Urticaria | 1990 |
Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Skin; Urticaria | 1990 |
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; Endocytosis; Furans; Humans; Hydroxyzine; In Vitro Techniques; Leukemia, Myeloid; Mice; Nifedipine; Phospholipid Ethers; Platelet Activating Factor; Pyridines; Quinidine; Quinine; Sodium Fluoride; Thiazoles; Triazoles; Verapamil | 1990 |
Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
Topics: Blood Platelets; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Cytotoxicity, Immunologic; Eosinophils; Humans; Hydroxyzine; Hypersensitivity; Immunoglobulin E; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1989 |
Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
Topics: Cell Survival; Cells, Cultured; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Eosinophils; Exocytosis; Humans; Hydroxyzine; In Vitro Techniques; L-Lactate Dehydrogenase; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1988 |